Multidisciplinary view of alcohol use disorder: From a psychiatric illness to a major liver disease

Biomolecules

Volumn 6, Issue 1, 2016, Pages

  Gitto, Stefano ^a   Golfieri, Lucia ^b   Caputo, Fabio ^b,c   Grandi, Silvana ^b   Andreone, Pietro ^d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SS Annunziata Hospital   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Alcohol liver disease; Alcohol use disorder; Liver transplantation

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ACAMPROSATE; BACLOFEN; DISULFIRAM; DOPAMINE BETA MONOOXYGENASE; NALMEFENE; NALTREXONE; OXYBATE SODIUM; OXYGENASE; ALCOHOL DERIVATIVE;

ABUSE; ACETALDEHYDE SYNDROME; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL USE DISORDER; ANOREXIA; ANXIETY; DIARRHEA; DROWSINESS; DSM-5; DYSPEPSIA; HEADACHE; HUMAN; INSOMNIA; LIVER DISEASE; LIVER INJURY; LIVER TRANSPLANTATION; MENTAL DISEASE; META ANALYSIS (TOPIC); METABOLIC DISORDER; MUSCLE HYPOTONIA; NAUSEA; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SOCIAL PROBLEM; WITHDRAWAL SYNDROME; ALCOHOLISM; EUROPE; LIVER DISEASES; PSYCHOLOGY;

ALCOHOL-RELATED DISORDERS; ALCOHOLS; BACLOFEN; EUROPE; HUMANS; LIVER DISEASES;

EID: 84978789746     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom6010011     Document Type: Review

References (82)

1. Maher, J. J. Alcoholic liver disease. In Gastrointestinal and Liver Disease; Feldman, M., Friedman, L. S., Sleisenger, M. H., Eds.; Saunders: Philadelphia, PA, USA, 2002; pp. 1375-1391.
2. Cochrane, J.; Chen, H.; Conigrave, K. M.; Hao, W. Alcohol use in China. Alcohol Alcohol. 2003, 38, 537-542. [CrossRef] [PubMed].
3. Anderson, P.; Baumberg, B. Alcohol in Europe: A Public Health Perspective; Institute of Alcohol Studies: London, UK, 2006.
4. Wittchen, H. U.; Jacobi, F. Size and burden of mental disorders in Europe-A critical review and appraisal of 27 studies. Eur. Neuropsychopharm. 2005, 15, 357-376. [CrossRef] [PubMed].
5. European Association for the Study of Liver. EASL clinical practical guidelines: Management of alcoholic liver disease. J. Hepatol. 2012, 57, 399-420.
6. What Is a Standard Drink? Available online: www. niaaa. nih. gov/alcohol-health/overview-alcoholconsumption/standard-drink (accessed on 1 September 2014).
7. Bagnardi, V.; Rota, M.; Botteri, E.; Tramacere, I.; Islami, F.; Fedirko, V.; Scotti, L.; Jenab, M.; Turati, F.; Pasquali, E.; et al. Light alcohol drinking and cancer: A meta-analysis. Ann. Oncol. 2013, 24, 301-308. [CrossRef].
8. Laramée, P.; Kusel, J.; Leonard, S.; Aubin, H. J.; François, C.; Daeppen, J. B. The economic burden of alcohol dependence in Europe. Alcohol Alcohol. 2013, 48, 259-269. [CrossRef] [PubMed].
9. Mohapatra, S.; Patra, J.; Popova, S.; Duhing, A.; Rehm, J. Social cost of heavy drinking and alcohol dependence in high-income countries. Int. J. Public Health 2010, 55, 149-157. [CrossRef] [PubMed].
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American Psychiatric Association: Washington, DC, USA, 2013; pp. 154-196.
11. Leggio, L.; Kenna, G. A.; Fenton, M.; Bonenfant, E.; Swift, R. M. Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol. Rev. 2009, 19, 115-129. [CrossRef] [PubMed].
12. Johnson, B. A. Medication treatment of different types of alcoholism. Am. J. Psychiatry 2010, 167, 630-639. [CrossRef] [PubMed].
13. Pombo, S.; Lesch, O. M. The alcoholic phenotypes among different multidimensional typologies: Similarities and their classification procedures. Alcohol Alcohol. 2009, 44, 46-54. [CrossRef] [PubMed].
14. Cloninger, C. R.; Bohman, M.; Sigvardsson, S. Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. Arch. Gen. Psych. 1981, 38, 861-868. [CrossRef].
15. Babor, T. F.; Hofmann, M.; del Boca, F. K.; Hesselbrock, V.; Meyer, R. E.; Dolinsky, Z. S.; Rounsaville, B. Types of alcoholics, I. Evidence for an empirically derived typology based on indicator of vulnerability and severity. Arch. Gen. Psychiatry 1992, 49, 599-608. [CrossRef] [PubMed].
16. Harnic, D.; Digiacomantonio, V.; Innamorati, M.; Mazza, M.; di Marzo, S.; Sacripanti, F.; Saioni, R.; Cardella, A.; di Felice, C.; Girardi, P.; et al. Temperament and attachment in alcohol addicted patients of type 1 and 2. Riv. Psichiatr. 2010, 5, 311-319.
17. Cibin, M.; Spolaor, G.; Hinnental, I.; Sgualdini, E.; Chiamulera, C. Residnetial treatment of alcohol use disorders: Thinking about the future. Alcologia 2015, 22, 41-47.
18. Sinha, R.; O'Malley, S. S. Craving for alcohol: Findings from the clinic and the laboratory. Alcohol Alcohol. 1999, 34, 223-230. [CrossRef] [PubMed].
19. Addolorato, G.; Abenavoli, L.; Leggio, L.; Gasbarrini, G. How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: A review. Neuropsychobiology 2005, 51, 59-66. [CrossRef] [PubMed].
20. Addolorato, G.; Leggio, L.; Abenavoli, L.; Gasbarrini, G. Alcoholism Treatment Study Group. Neurobiochemical and clinical aspects of craving in alcohol addiction: A review. Addict. Behav. 2005, 30, 1209-1224. [CrossRef] [PubMed].
21. Martinotti, G.; di Nicola, M.; Tedeschi, D.; Callea, A.; di Giannantonio, M.; Janiri, L.; Craving Study Group. Craving Typology Questionnaire (CTQ): A scale for alcohol craving in normal controls and alcoholics. Compr. Psychiatry 2013, 54, 925-932. [CrossRef] [PubMed].
22. Zakhari, S.; Li, T. Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease. Hepatology 2007, 46, 2032-2039. [CrossRef] [PubMed].
23. Pincock, S. Binge drinking on rise in UK and elsewhere. Lancet 2003, 362, 1126-1127. [CrossRef].
24. Naimi, T. S.; Brewer, R.; Mokdad, A.; Denny, C.; Serdula, M. K.; Marks, J. S. Binge drinking among US adult. JAMA 2003, 289, 70-75. [CrossRef] [PubMed].
25. Mathurin, P.; Delterne, P. Effect of binge drinking on the liver: An alarming public health issue? Gut 2009, 58, 613-617. [CrossRef] [PubMed].
26. Litten, R. Z.; Egli, M.; Heilig, M.; Cui, C.; Fertig, J. B.; Ryan, M. L.; Falk, D. E.; Moss, H.; Huebner, R.; Noronha, A. Medications development to treat alcohol dependence: A vision for the next decade. Addict. Biol. 2012, 17, 513-527. [CrossRef] [PubMed].
27. Neuberger, J.; Adams, D.; MacMaster, P.; Maidment, A.; Speed, M. Assessing priorities for allocation of donor liver grafts: Survey of and clinicians. BMJ 1998, 317, 172-175. [CrossRef].
28. Gitto, S.; Vitale, G.; Villa, E.; Andreone, P. Update on Alcohol and Viral Hepatitis. J. Clin. Transl. Hepatol. 2014, 2, 228-233. [CrossRef] [PubMed].
29. Samokhvalov, A. V.; Popova, S.; Room, R.; Ramonas, M.; Rehm, J. Disability associated with alcohol abuse and dependence. Alcohol. Clin. Exp. Res. 2010, 34, 1871-1878. [CrossRef] [PubMed].
30. Mathurin, P.; Bataller, R. Trends in the management and burden of alcoholic liver disease. J. Hepatol. 2015, 62, S38-S46. [CrossRef] [PubMed].
31. Singh, V.; Epstein-Ngo, Q.; Cunningham, R. M.; Stoddard, S. A.; Chermack, S. T.; Walton, M. A. Physical dating violence among adolescents and young adults with alcohol misuse. Drug Alcohol Depend. 2015, 163, 364-368. [CrossRef] [PubMed].
32. Leon, D. A.; Mc Cambridge, J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: An analysis of routine data. Lancet 2006, 367, 52-56. [CrossRef].
33. Wagenaar, A. C.; Tobler, A. L.; Komro, K. A. Effects of alcohol tax and price policies on morbidity and mortality: A systematic review. Am. J. Public Health 2010, 100, 2270-2278. [CrossRef] [PubMed].
34. Guideline on the Development of Medicinal Products for the Treatment of Alcohol Dependence. Available online: http://www. ema. europa. eu/docs/en_GB/document_library/Scientific_guideline/2010/03/WC 50004898. pdf (accessed on 1 March 2013).
35. Amato, L.; Minozzi, S.; Davoli, M.; Vecchi, S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst. Rev. 2011. [CrossRef].
36. Kaner, E. F.; Beyer, F.; Dickinson, H. O.; Pienaar, E.; Campbell, F.; Schlesinger, C.; Heather, N.; Saunders, J.; Burnand, B. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst. Rev. 2007. [CrossRef].
37. Whitlock, E. P.; Polen, M. R.; Green, C. A.; Orleans, T.; Klein, J. Behavioural counselling interventions in primary care to reduce risky/harmful alcohol use by adults: A summary of the evidence for the U. S. Preventive services task force. Ann. Intern. Med. 2004, 140, 557-568. [CrossRef] [PubMed].
38. Klimas, J.; Tobin, H.; Field, C. A.; O'Gorman, C. S.; Glynn, L. G.; Keenan, E.; Saunders, J.; Bury, G.; Dunne, C.; Cullen, W. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. Cochrane Database Syst. Rev. 2014. [CrossRef].
39. Klimkiewicz, A.; Klimkiewicz, J.; Jakubczyk, A.; Kieres-Salomónski, I.; Wojnar, M. Comorbidity of alcohol dependence with other psychiatric disorders. Part I. Epidemiology of dual diagnosis. Psychiatr. Pol. 2015, 49, 265-275. [CrossRef] [PubMed].
40. Krampe, H.; Ehrenreich, H. Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr. Pharm. Des. 2010, 16, 2076-2090. [CrossRef] [PubMed].
41. European Public Assessment Reports. Available online: http://www. ema. europa. eu/ema/index. jsp?curl= pages/medicines/landing/epar_search. jsp&mid=WC0b01ac058001d125 (accessed on 1 January 2013).
42. Chick, J. Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Saf. 1999, 20, 427-435. [CrossRef] [PubMed].
43. Caputo, F.; Vignoli, T.; Grignaschi, A.; Cibin, M.; Addolorato, G.; Bernardi, M. Pharmacological management of alcohol dependence: From mono-therapy to pharmacogenetics and beyond. Eur. Neuropsychopharmacol. 2014, 24, 181-191. [CrossRef] [PubMed].
44. Rösner, S.; Hackl-herrwerth, A.; Leucht, S.; Vecchi, S.; Srisurapanont, M.; Soyka, M. Opioid antagonists for alcohol dependence. Cochrane Database Syst. Rev. 2010. [CrossRef].
45. Anton, R. F.; Oroszi, G.; O'Malley, S.; Couper, D.; Swift, R.; Pettinati, H.; Goldman, D. An evaluation of muopioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: Results from the combined pharmacotherapies and behavioural interventions for alcohol dependence (COMBINE) study. Arch. Gen. Psychiatry 2008, 65, 135-144. [CrossRef] [PubMed].
46. DeWitte, P.; Littleton, J.; Parot, P.; Koob, G. Neuroprotective and abstinence-promoting effects of acamprosate: Elucidating the mechanism of action. CNS Drugs 2005, 19, 517-537. [CrossRef] [PubMed].
47. Rösner, S.; Hackl-herrwerth, A.; Leucht, S.; Lehert, P.; Vecchi, S.; Soyka, M. Acamprosate for alcohol dependence. Cochrane Database Syst. Rev. 2010, 8, CD004332.
48. Snead, O. C.; Gibson, K. M. Gamma-hydroxybutyric acid. N. Engl. J. Med. 2005, 352, 2721-2732. [CrossRef] [PubMed].
49. Caputo, F.; Bernardi, M. Medications acting on the GABA system in the treatment of alcoholic patients. Curr. Pharm. Des. 2010, 16, 2118-2125. [CrossRef] [PubMed].
50. Leone, M. A.; Vigna-Taglianti, F.; Avanzi, G.; Brambilla, R.; Faggiano, F. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst. Rev. 2010. [CrossRef].
51. Keating, G. M. Sodium oxybate: A review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Clin. Drug Investig. 2014, 34, 63-80. [CrossRef] [PubMed].
52. Skala, K.; Caputo, F.; Mirijello, A.; Vassallo, G.; Antonelli, M.; Ferrulli, A.; Walter, H.; Lesch, O.; Addolorato, G. Sodium oxybate in the treatment of alcohol dependence: From the alcohol withdrawal syndrome to the alcohol relapse prevention. Expert Opin. Pharmacother. 2014, 15, 245-257. [CrossRef] [PubMed].
53. Mann, K.; Bladström, A.; Torup, L.; Gual, A.; Van den Brink, W. Extending the treatment options in alcohol dependence: A randomized controlled study of as-needed nalmefene. Biol. Psychiatry 2013, 73, 706-713. [CrossRef] [PubMed].
54. Gual, A.; Heb, Y.; Torup, L.; van den Brink, V.; Mann, K.; ESENSE 2 study group. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur. Neuropsychopharmacol. 2013, 23, 1432-1442. [CrossRef] [PubMed].
55. Addolorato, G.; Leggio, L.; Ferrulli, A.; Cardone, S.; Vonghia, L.; Mirijello, A.; Abenavoli, L.; D'Angelo, C.; Caputo, F.; Zambon, A.; et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: Randomised, double-blind controlled study. Lancet 2007, 370, 1915-1922. [CrossRef].
56. Addolorato, G.; Leggio, L.; Agabio, R.; Colombo, G.; Gasbarrini, G. Baclofen: A new drug for the treatment of alcohol dependence. Int. J. Clin. Pract. 2006, 60, 1003-1008. [CrossRef] [PubMed].
57. Yamini, D.; Lee, S. H.; Avanesyan, A.; Walter, M.; Runyon, B. Utilization of baclofen in maintenance of alcohol abstinence in aptients with alcohol dependence and alcohol hepatitis with or without cirrhosis. Alcohol Alcohol. 2014, 49, 453-456. [CrossRef] [PubMed].
58. Corrao, G.; Ferrari, P.; Zambon, A.; Torchio, P.; Arico, S.; Decarli, A. Trends of liver cirrhosis mortality in Europe, 1970-1989: Age-period-cohort analysis and changing alcohol consumption. Int. J. Epidemiol. 1997, 26, 100-109. [CrossRef] [PubMed].
59. Ramstedt, M. Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries. Addiction 2001, 96, S19-S33. [CrossRef] [PubMed].
60. Testino, G. Alcoholic diseases in hepato-gastroenterology: A point of view. Hepatogastroenterology 2008, 55, 371-377. [PubMed].
61. Askgaard, G.; Gronbaek, M.; Kjaer, M. S. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: A prospective cohort study. J. Hepatol. 2015. in press. [CrossRef] [PubMed].
62. Corrao, G.; Bagnardi, V.; Zambon, A.; Torchio, P. Meta-analysis of alcohol intake in relation to risk of liver cirrhosis. Alcohol Alcohol. 1998, 33, 381-392. [CrossRef] [PubMed].
63. Mathurin, P.; Lucey, M. R. Management of alcoholic hepatitis. J. Hepatol. 2012, 56, S39-S45. [CrossRef].
64. Testino, G. Alcoholic hepatitis. J. Med. Life 2013, 6, 161-167. [PubMed].
65. Poynard, T.; Mathurin, P.; Lai, C. L.; Guyader, D.; Poupon, R.; Tainturier, M. H.; Myers, R. P.; Muntenau, M.; Ratziu, V.; Manns, M.; et al. A comparison of fibrosis progression in chronic liver diseases. J. Hepatol. 2003, 38, 257-265. [CrossRef].
66. Hrubec, Z.; Omenn, G. S. Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: Twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol. Clin. Exp. Res. 1981, 5, 207-215. [CrossRef] [PubMed].
67. Liu, Y. L.; Patman, G. L.; Leathart, J. B.; Piguet, A. C.; Burt, A. D.; Dufour, J. F.; Day, C. P.; Daly, A. K.; Reeves, H. L.; Anstee, Q. M. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J. Hepatol. 2014, 61, 75-81. [CrossRef].
68. Dam-Larsen, S.; Franzmann, M.; Andersen, I. B.; Christoffersen, P.; Jensen, L. B.; Sørensen, T. I.; Becker, U.; Bendtsen, F. Long term prognosis of fatty liver: Risk of chronic liver disease and death. Gut 2004, 53, 750-755. [CrossRef].
69. Mathurin, P.; Beuzin, F.; Louvet, A.; Carrie-Ganne, N.; Balian, A.; Trinchet, J. C.; Dalsoglio, D.; Prevot, S.; Naveau, S. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment. Pharmacol. Ther. 2007, 25, 1047-1054. [CrossRef] [PubMed].
70. Naveau, S.; Giraud, V.; Borotto, E.; Aubert, A.; Capron, F.; Chaput, J. C. Excess weight risk factor for alcoholic liver disease. Hepatology 1997, 25, 108-111. [CrossRef] [PubMed].
71. Raynard, B.; Balian, A.; Fallik, D.; Capron, F.; Bedossa, P.; Chaput, J. C.; Naveau, S. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002, 35, 635-638. [CrossRef] [PubMed].
72. Lucey, M. R.; Schaubel, D. E.; Guidinger, M. K.; Tome, S.; Merion, R. M. Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and trans-plant survival benefit. Hepatology 2009, 50, 400-406. [CrossRef] [PubMed].
73. Biselli, M.; Gramenzi, A.; del Gaudio, M.; Ravaioli, M.; Vitale, G.; Gitto, S.; Grazi, G. L.; Pinna, A. D.; Andreone, P.; Bernardi, M.; et al. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: A single center case-control study. J. Clin. Gastroenterol. 2010, 44, 52-57. [CrossRef] [PubMed].
74. Pfitzmann, R.; Schwenzer, J.; Rayes, N.; Seehofer, D.; Neuhaus, R.; Nüssler, N. C. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl. 2007, 13, 197-205. [CrossRef] [PubMed].
75. Gaglio, P. J., Jr.; Gaglio, P. J. Complications in patients with alcohol-associated liver disease who undergo liver transplantation. Clin. Liver Dis. 2012, 16, 865-875. [CrossRef] [PubMed].
76. Leong, J.; Im, G. Y. Evaluation and selection of the patient with alcoholic liver disease for liver transplant. Clin. Liver Dis. 2012, 16, 851-863. [CrossRef] [PubMed].
77. Varma, V.; Webb, K.; Mirza, D. F. Liver transplantation for alco-holic liver disease. World J. Gastroenterol. 2010, 16, 4377-4393. [CrossRef] [PubMed].
78. Regione Autonoma Friuli Venezia Giulia. Available online: http://www. mediofriuli. it (accessed on 1 March 2015).
79. Testino, G.; Sumberaz, A.; Borro, P. Comment to "liver transplantation for patients with alcoholic liver disease: An open question". Dig. Liver Dis. 2013, 45, 80-81. [CrossRef] [PubMed].
80. Pilling, S.; Yesufu-Udechuku, A.; Taylor, C.; Drummond, C. Diagnosis, assessment, and management of harmful drinking and alcohol dependence: Summary of NICE guidance. BMJ 2011. [CrossRef] [PubMed].
81. Curzio, O.; Tilli, A.; Mezzasalma, L.; Scalese, M.; Fortunato, L.; Potente, R.; Guidoni, G.; Molinaro, S. Characteristics of alcoholics attending "clubs of alcoholics in treatment" in Italy: A national survey. Alcohol Alcohol. 2012, 47, 317-321. [CrossRef] [PubMed].
82. Testino, G.; Burra, P.; Bonino, F.; Piani, F.; Sumberaz, A.; Peressutti, R.; Giannelli Castiglione, A.; Patussi, V.; Fanucchi, T.; Ancarani, O.; et al. Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement. World J. Gastroenterol. 2014, 40, 14642-14651. [CrossRef] [PubMed].